Literature DB >> 31301850

The Unexpected Noncatalytic Roles of Histone Modifiers in Development and Disease.

Yann Aubert1, Shaun Egolf1, Brian C Capell2.   

Abstract

Epigenetic regulation is critical for the precise control of cellular fate and developmental programs. Disruption of epigenetic information is increasingly appreciated as a potential driving mechanism in both developmental disorders as well as ubiquitous diseases such as cancer. Consistent with this, mutations in histone modifying enzymes are amongst the most frequent events in all of human cancer. While early studies have focused on the canonical enzymatic functions involved in catalyzing modifications to histones, more recent studies have uncovered a new layer of critical nonenzymatic roles in transcriptional regulation for these proteins. Here, we provide an overview of these surprising, yet exciting, noncanonical, noncatalytic roles, and highlight how these revelations may have important implications for understanding disease and the future of epigenome-targeting therapies.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31301850      PMCID: PMC6697606          DOI: 10.1016/j.tig.2019.06.004

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  96 in total

1.  Histone H3K27ac separates active from poised enhancers and predicts developmental state.

Authors:  Menno P Creyghton; Albert W Cheng; G Grant Welstead; Tristan Kooistra; Bryce W Carey; Eveline J Steine; Jacob Hanna; Michael A Lodato; Garrett M Frampton; Phillip A Sharp; Laurie A Boyer; Richard A Young; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-24       Impact factor: 11.205

2.  The H3K4 methyltransferase Setd1a is first required at the epiblast stage, whereas Setd1b becomes essential after gastrulation.

Authors:  Anita S Bledau; Kerstin Schmidt; Katrin Neumann; Undine Hill; Giovanni Ciotta; Ashish Gupta; Davi Coe Torres; Jun Fu; Andrea Kranz; A Francis Stewart; Konstantinos Anastassiadis
Journal:  Development       Date:  2014-03       Impact factor: 6.868

3.  Characterization of Individual Histone Posttranslational Modifications and Their Combinatorial Patterns by Mass Spectrometry-Based Proteomics Strategies.

Authors:  Simone Sidoli; Benjamin A Garcia
Journal:  Methods Mol Biol       Date:  2017

4.  EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex.

Authors:  Ji Min Lee; Jason S Lee; Hyunkyung Kim; Kyeongkyu Kim; Hyejin Park; Ji-Young Kim; Seung Hoon Lee; Ik Soo Kim; Joomyung Kim; Minkyoung Lee; Chin Ha Chung; Sang-Beom Seo; Jong-Bok Yoon; Eunyoung Ko; Dong-Young Noh; Keun Il Kim; Kyeong Kyu Kim; Sung Hee Baek
Journal:  Mol Cell       Date:  2012-10-11       Impact factor: 17.970

5.  LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.

Authors:  Wanqiang Sheng; Martin W LaFleur; Thao H Nguyen; Sujun Chen; Ankur Chakravarthy; Jake Ryan Conway; Ying Li; Hao Chen; Henry Yang; Pang-Hung Hsu; Eliezer M Van Allen; Gordon J Freeman; Daniel D De Carvalho; Housheng Hansen He; Arlene H Sharpe; Yang Shi
Journal:  Cell       Date:  2018-06-21       Impact factor: 41.582

Review 6.  Ever-Changing Landscapes: Transcriptional Enhancers in Development and Evolution.

Authors:  Hannah K Long; Sara L Prescott; Joanna Wysocka
Journal:  Cell       Date:  2016-11-17       Impact factor: 41.582

7.  Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.

Authors:  Kristel M Dorighi; Tomek Swigut; Telmo Henriques; Natarajan V Bhanu; Benjamin S Scruggs; Nataliya Nady; Christopher D Still; Benjamin A Garcia; Karen Adelman; Joanna Wysocka
Journal:  Mol Cell       Date:  2017-05-05       Impact factor: 17.970

8.  MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis.

Authors:  Binbin Lai; Ji-Eun Lee; Younghoon Jang; Lifeng Wang; Weiqun Peng; Kai Ge
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

9.  Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator.

Authors:  Jung Kim; Yongik Lee; Xiaodong Lu; Bing Song; Ka-Wing Fong; Qi Cao; Jonathan D Licht; Jonathan C Zhao; Jindan Yu
Journal:  Cell Rep       Date:  2018-12-04       Impact factor: 9.423

10.  Jmjd3 contributes to the control of gene expression in LPS-activated macrophages.

Authors:  Francesca De Santa; Vipin Narang; Zhei Hwee Yap; Betsabeh Khoramian Tusi; Thomas Burgold; Liv Austenaa; Gabriele Bucci; Marieta Caganova; Samuele Notarbartolo; Stefano Casola; Giuseppe Testa; Wing-Kin Sung; Chia-Lin Wei; Gioacchino Natoli
Journal:  EMBO J       Date:  2009-09-24       Impact factor: 11.598

View more
  10 in total

Review 1.  SETD2: from chromatin modifier to multipronged regulator of the genome and beyond.

Authors:  Thom M Molenaar; Fred van Leeuwen
Journal:  Cell Mol Life Sci       Date:  2022-06-06       Impact factor: 9.207

Review 2.  X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.

Authors:  Rossella Tricarico; Emmanuelle Nicolas; Michael J Hall; Erica A Golemis
Journal:  Clin Cancer Res       Date:  2020-07-30       Impact factor: 12.531

Review 3.  LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma?

Authors:  Shaun Egolf; Brian C Capell
Journal:  Expert Opin Ther Targets       Date:  2020-05-07       Impact factor: 6.902

4.  Epigenetic and metabolic interplay in cutaneous squamous cell carcinoma.

Authors:  Gina Pacella; Brian C Capell
Journal:  Exp Dermatol       Date:  2021-04-22       Impact factor: 3.960

Review 5.  Clinical Manifestations and Epigenetic Regulation of Oral Herpesvirus Infections.

Authors:  Natalie Atyeo; Michelle D Rodriguez; Bernadett Papp; Zsolt Toth
Journal:  Viruses       Date:  2021-04-15       Impact factor: 5.048

Review 6.  Alterations of Chromatin Regulators in the Pathogenesis of Urinary Bladder Urothelial Carcinoma.

Authors:  Michèle J Hoffmann; Wolfgang A Schulz
Journal:  Cancers (Basel)       Date:  2021-11-30       Impact factor: 6.639

7.  KDM4B promotes acute myeloid leukemia associated with AML1-ETO by regulating chromatin accessibility.

Authors:  Takeshi Ueda; Akinori Kanai; Akiyoshi Komuro; Hisayuki Amano; Kazushige Ota; Masahiko Honda; Masahito Kawazu; Hitoshi Okada
Journal:  FASEB Bioadv       Date:  2021-09-12

8.  Release of CHK-2 from PPM-1.D anchorage schedules meiotic entry.

Authors:  Antoine Baudrimont; Dimitra Paouneskou; Ariz Mohammad; Raffael Lichtenberger; Joshua Blundon; Yumi Kim; Markus Hartl; Sebastian Falk; Tim Schedl; Verena Jantsch
Journal:  Sci Adv       Date:  2022-02-16       Impact factor: 14.136

Review 9.  Histone Mono-Ubiquitination in Transcriptional Regulation and Its Mark on Life: Emerging Roles in Tissue Development and Disease.

Authors:  Liat Oss-Ronen; Tzlil Sarusi; Idan Cohen
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

10.  Mutually suppressive roles of KMT2A and KDM5C in behaviour, neuronal structure, and histone H3K4 methylation.

Authors:  Christina N Vallianatos; Brynne Raines; Robert S Porter; Katherine M Bonefas; Michael C Wu; Patricia M Garay; Katie M Collette; Young Ah Seo; Yali Dou; Catherine E Keegan; Natalie C Tronson; Shigeki Iwase
Journal:  Commun Biol       Date:  2020-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.